Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway - Journal of Experimental & Clinical Cancer Research

Background Discovery and development of novel drugs that are capable of overcoming drug resistance in tumor cells are urgently needed clinically. In this study, we sought to explore whether ivermectin (IVM), a macrolide antiparasitic agent, could overcome the resistance of cancer cells to the thera…